Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity

Vaccine-induced seroreactivity/positivity (VISR/P) poses a significant and common challenge to HIV vaccine implementation, as up to 95% of vaccine recipients may be misclassified as having HIV infection by current HIV screening and confirmatory serological assays. We investigated whether internal HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagatie, Ole, Lauwers, Dax, Singh, Harvinder, Vanroye, Fien, Stieh, Daniel J., Vingerhoets, Johan, Lavreys, Ludo, Oriol-Mathieu, Valérie, Colón, Will, Verhofstede, Chris, Vercauteren, Koen, Van den Bossche, Dorien, Pau, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269835/
https://www.ncbi.nlm.nih.gov/pubmed/37222611
http://dx.doi.org/10.1128/spectrum.00715-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269835/
https://www.ncbi.nlm.nih.gov/pubmed/37222611
http://dx.doi.org/10.1128/spectrum.00715-23

Ejemplares similares